Hemodynamic Support Devices

Impella, FDA, high risk PCI

The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) clearance for Abiomed’s Impella 2.5 heart pump during elective and urgent high-risk percutaneous coronary intervention (PCI) procedures.

July 18, 2014 — The Freedom portable driver has received U.S. Food and Drug Administration (FDA) approval for use with the SynCardia temporary total artificial heart as a bridge to transplantation in cardiac transplant candidates who are clinicall...

ECRI Institute, review, Impella RP, Abiomed
ECRI Institute recently reviewed published data on Abiomed’s Impella RP (Right Percutaneous) transcatheter ventricular assist device (VAD). The institute said...
UH Case Medical Center, Impella RP, first in Ohio, Abiomed, Mobile Learning Lab
University Hospitals Case Medical Center physicians in the Harrington Heart & Vascular Institute were the first in Ohio to implant a new device to treat...
Beaumont Hospital Royal Oak, Impella RP, right-side heart failure, Abiomed
Beaumont Hospital, Royal Oak is one of the first centers in the United States to use a new minimally invasive heart pump designed to provide temporary support...
IABP, peer review, Maquet, Journal of Invasive Cardiology
Maquet Getinge Group announced the publication of a manuscript describing the exploration of the hemodynamic effects of the newer, larger-capacity 50 cc intra-...
Impella, FDA, high risk PCI, abiomed
Abiomed’s Impella 2.5 heart pump has gained an additional FDA vindication for use during elective and urgent high-risk percutaneous
CardiacAssist's Protek Duo veno‐venous cannula is intended for use as a single cannula for both venous drainage and reinfusion of...
SynCardia SynHall valves, use in the SynCardia Heart, are of the same design, materials and nearly identical manufacturing processes as the...
The Freedom portable driver is U.S. Food and Drug Administration (FDA)-approved for use with the SynCardia temporary total artificial heart...

Articles

IABP, peer review, Maquet, Journal of Invasive Cardiology
Maquet Getinge Group announced the publication of a manuscript describing the exploration of the hemodynamic effects of the newer, larger-capacity 50 cc intra-...
expert consensus, SCAI, ACC, HFSA, STS, heart pumps, MCS devices
An expert consensus statement released by four leading cardiovascular societies provides new guidance on percutaneous mechanical circulatory support (MCS)...
Impella, FDA, high risk PCI, abiomed
The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) clearance for Abiomed’s Impella 2.5 heart pump during elective and urgent...
absorb, bioresorbable stents
DAIC readers chose the following stories as the most popular content in 2014, based on website analytics. The list is broken into the top 20 most popular news...

Video Center

Here are a few observations on cardiovascular ultrasound advances I made while attending the 2015...
6 days 13 hours ago
The latest advances in cardiovascular echocardiography will be presented at the 2015 American...
3 weeks 2 days ago
There were several technology takeaway messages for the future of electrophysiology (EP) at the...
6 weeks 2 days ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...

Comparison Charts

Sorry there is no data available